Platelet-Derived Growth Factor Subunit A Strengthens the Neurovascular Unit and Inhibits Retinal Vascular Regression Under Hyperoxic Conditions
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312945 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kaito Yokota und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Osaka, Japan. Hauptthemen laut MEDLINE: Platelet-Derived Growth Factor, Hyperoxia, Retinopathy of Prematurity, Retinal Vessels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMO Japan Contract Research Grant.
Abstract (Originalsprache)
Retinopathy of prematurity (ROP) is primarily caused by the exposure of preterm infants with underdeveloped blood vessels to high oxygen concentrations. This damages the astrocytes that promote normal vascular development, leading to avascularity, pathological neovascularization, and retinal detachment, and even blindness as the disease progresses. In this study, the aim was to investigate the differences in the characteristics of astrocytes and blood vessels between wild-type (WT) and genetically modified mice overexpressing platelet-derived growth factor subunit A (PDGF-A) in the retina immediately after high oxygen exposure, a protocol in the oxygen-induced retinopathy (OIR) model of ROP. Our results showed that PDGF-A mice exhibited an increased population of astrocytes and higher vascular density than WT mice and that PDGF-A strengthened the resistance to hyperoxic conditions. In the OIR model, PDGF-A mice had reduced avascular zone areas following hyperoxia exposure. Furthermore, immunostaining for NG2 and CD31 showed that pericytes tended to regress earlier than endothelial cells, particularly at the vessel edges in both WT and transgenic mice, indicating relatively higher susceptibility to hyperoxia-induced damage. These findings suggest that PDGF-A plays a crucial role in stabilizing retinal vessels and may serve as a novel therapeutic target for ROP, highlighting the potential significance of PDGF-A in the pathological mechanisms of retinal diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Kansai Medical University, 2-5-1 Shin-machi, Hirakata 573-1010, Osaka, Japan.
ORCID-Profile: Kaito Yokota, Haruhiko Yamada, Hidetsugu Mori, Keiko Toyama, Hisanori Imai
Förderung
- AMO Japan Contract Research Grant
Zitieren
APA
Yokota, K., Yamada, H., Mori, H., Hattori, Y., Omi, M., Yamamoto, Y., Toyama, K., & Imai, H. (2024). Platelet-Derived Growth Factor Subunit A Strengthens the Neurovascular Unit and Inhibits Retinal Vascular Regression Under Hyperoxic Conditions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312945
Vancouver
Yokota K, Yamada H, Mori H, Hattori Y, Omi M, Yamamoto Y, et al. Platelet-Derived Growth Factor Subunit A Strengthens the Neurovascular Unit and Inhibits Retinal Vascular Regression Under Hyperoxic Conditions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312945
BibTeX
@article{Yokota2024,
author = {Yokota, Kaito and Yamada, Haruhiko and Mori, Hidetsugu and Hattori, Yuki and Omi, Masatoshi and Yamamoto, Yuichi and Toyama, Keiko and Imai, Hisanori},
title = {Platelet-Derived Growth Factor Subunit A Strengthens the Neurovascular Unit and Inhibits Retinal Vascular Regression Under Hyperoxic Conditions},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312945}
}
EUVIMED